Close Menu
    GCC TelegraphGCC Telegraph
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    GCC TelegraphGCC Telegraph
    Home » South Korean Biotech Company Portrai Inc. Adopts Infortrend Storage to Enable AI Data Analysis for Pharmaceutical Drug Development
    PR Newswire

    South Korean Biotech Company Portrai Inc. Adopts Infortrend Storage to Enable AI Data Analysis for Pharmaceutical Drug Development

    September 12, 2023
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    TAIPEI, Sept. 12, 2023 /PRNewswire/ —  Infortrend® Technology, Inc. (TWSE: 2495), the industry-leading enterprise storage manufacturer, provided South Korean biotech company Portrai Inc. with EonStor GS enterprise unified storage solution to enable their innovative research technology combining AI and RNA analysis for pharmaceutical drug development.

    Portrai Inc. specializes in a cutting-edge RNA analysis technology called “Spatial Transcriptomics” to study novel targets and disease-related biomarkers. The company uses the unique combination of AI and Spatial Transcriptomics aiming to revolutionize pharmaceutical drug development. This analysis technology continuously generates data ranging from 10GB to 1TB for an image sized 1cm2, which requires storage space. Cloud storage solutions were hindered due to low internet throughput and expensive monthly subscriptions for enterprise-grade plans. Thus, the company was looking for a reasonably priced on-site solution capable of storing and processing massive amounts of research data generated by AI computation.

    Portrai chose Infortrend’s storage for its reputation of system stability and performance. To enable their advanced and demanding RNA analysis technology, the biotech company was advised to deploy Infortrend’s EonStor GS 3024 unified storage and JBOD JB3060L, fully loaded with 84 NL-SAS drives x 18TB. This solution easily tackled the demand for data storage by offering up to 1.2PB of available storage. Moreover, it features a redundant controller design to minimize downtime, data replication/mirroring for backup, future scalability for the ever-growing research data, and efficient management with the browser-based  interface.

    “In the course of pharmaceutical drug development, Spatial Transcriptomics and AI analysis generate massive amounts of data. Infortrend offers storage stability and capacity, combined with reasonable pricing, good customer service, and technical support, so we are extremely satisfied with Infortrend’s storage solution,” said Daeseung Lee, CEO of Portrai Inc.

    Learn more about EonStor GS

    Connect with Infortrend on LinkedIn

    Contact Infortrend to Make an Inquiry

    About Infortrend

    Infortrend (TWSE: 2495) has been developing and manufacturing storage solutions since 1993. With a strong emphasis on in-house design, testing, and manufacturing, Infortrend storage delivers performance and scalability with the latest standards, user friendly data services, personal after-sales support, and unrivaled value. For more information, please visit www.infortrend.com

    Infortrend® and EonStor® are trademarks or registered trademarks of Infortrend Technology, Inc.; other trademarks are the property of their respective owners.

    Cision View original content:https://www.prnewswire.com/ru/press-releases/south-korean-biotech-company-portrai-inc-adopts-infortrend-storage-to-enable-ai-data-analysis-for-pharmaceutical-drug-development-301920900.html

    Related Posts

    QIA Anchors Public Power Corporation’s Share Capital Increase

    May 25, 2026

    Armaf Unveils ‘Soda Pop’, a New Gourmand Fragrance from the Odyssey Collection

    May 25, 2026

    Gorenje Introduces the G800 Built-In Oven, Bringing More Space, Smarter Cooking, and Summer-Ready Convenience to Middle Eastern Homes

    May 25, 2026

    ZOE Energy Storage Partners with Local Saudi Ally to Build Kingdom’s First World-Class Battery Storage Manufacturing Base

    May 25, 2026

    Sentire® Surgical System Receives CE Mark (MDR) Approval, Cornerstone Robotics Enters a New Era in its Global Expansion

    May 25, 2026

    From Pakistan to Shanghai: A CAR-T Journey Fighting Relapsed Lymphoma

    May 25, 2026
    Latest News

    Measles outbreak in Bangladesh passes 60,000 cases

    May 23, 2026

    Bangladesh’s measles outbreak has passed 60,000 suspected cases, with confirmed and suspected child deaths nearing 500.

    PM Modi and Meloni spotlight deepening India-Italy ties

    May 21, 2026

    UAE and Germany review strategic ties in Berlin

    May 21, 2026

    South Korea launches $665.5 million industrial growth fund

    May 20, 2026

    Etihad expands Paris route with double daily A380 flights

    May 20, 2026

    Japan and South Korea launch energy security framework

    May 20, 2026

    GME posts strongest trading week in two decades

    May 19, 2026

    Porsche reveals bespoke 911 GT3 RS in Macadamiametallic

    May 18, 2026
    © 2026 GCC Telegraph | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.